| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.099 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |